Sonolysis Reduces CV Events During Carotid Endarterectomy: Insights from the SONOBIRDIE Trial
Researchers have found in a new trial that Sonolysis Reduces CV Events During Carotid Endarterectomy. The SONOBIRDIE trial, a multicenter, randomized, double-blind, sham-controlled study, evaluated the efficacy and safety of sonolysis-continuous transcranial Doppler (TCD) monitoring using a 2-MHz diagnostic probe—during carotid endarterectomy (CEA).
The trial demonstrated that sonolysis significantly reduced the incidence of periprocedural cerebrovascular events, including stroke and transient ischemic attacks (TIA), without increasing the risk of intracranial hemorrhages.
A study was done to evaluate the effectiveness and safety of sonolysis using a low intensity 2 MHz pulsed wave ultrasound beam during carotid endarterectomy. Participants 1004 patients (mean age 68 years; 312 (31%) female) were enrolled in the study between 20 August 2015 and 14 October 2020 until the interim analysis was performed.
The primary endpoint was the composite incidence of ischaemic stroke, transient ischaemic attack, and death within 30 days.
The incidence of new ischaemic lesions on follow-up brain magnetic resonance imaging was the main substudy endpoint, and incidence of intracranial bleeding was the main safety endpoint. Results The results favoured the sonolysis group for the primary endpoint (11 (2.2%) v 38 (7.6%); risk difference −5.5%, 95% confidence interval (CI) −8.3% to −2.8%; P<0.001), as well as in the substudy for magnetic resonance imaging detected new ischaemic lesions (20/236 (8.5%) v 39/224 (17.4%); risk difference −8.9%, −15% to −2.8%; P=0.004).
Sensitivity analysis resulted in a risk ratio for sonolysis of 0.25 (95% CI 0.11 to 0.56) for ischaemic stroke and 0.23 (0.07 to 0.73) for transient ischaemic attack within 30 days. Sonolysis was found to be safe, and 94.4% of patients in the sonolysis group were free from serious adverse events 30 days after the procedure. Sonolysis was safe for patients undergoing carotid endarterectomy and resulted in a significant reduction in the composite incidence of ischaemic stroke, transient ischaemic attack, and death within 30 days.
Reference:
Školoudík D, et al "Sonolysis during carotid endarterectomy: randomised controlled trial" BMJ 2025; DOI: 10.1136/bmj-2024-082750.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.